Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Strong

Showing results (171-180 of 182) with videos related to

Pageof 19
Sort By:
Chimerism|October 15, 2013
Trogocytosis as a mechanistic link between chimerism and prenatal toleranceAmir M Alhajjat, Beverly S Strong, Emily T Durkin, et al.
Progress in Clinical and Biological Research|January 1, 1985
Sequential response patterns to chemotherapy and radiotherapy in head and neck cancer: potential impact of treatment in advanced laryngeal cancerW K Hong, G M O'Donoghue, S Sheetz, et al.
American Journal of Clinical Oncology|June 1, 1984
Induction bleomycin infusion in head and neck cancerJ D Popkin, W K Hong, R H Bromer, et al.
Journal of Clinical Apheresis|January 1, 1985
Plasma exchange in six patients with advanced cancers of the head and neckR H Seder, A E Katz, J J Keggins, et al.
Drug and Alcohol Dependence|June 24, 2023
Opioid and stimulant attributed treatment admissions and fatal overdoses: Using national surveillance data to examine the intersection of race, sex, and polysubstance use, 1992-2020A A Jones, R D Shearer, J E Segel, et al.
Cancer|July 15, 1983
A prospective randomized trial of methotrexate versus cisplatin in the treatment of recurrent squamous cell carcinoma of the head and neckW K Hong, S Schaefer, B Issell, et al.
American Journal of Clinical Oncology|June 1, 1983
Continuous vindesine infusion in advanced head and neck cancerJ D Popkin, R H Bromer, C W Vaughan, et al.
Annals of Internal Medicine|April 15, 2000
Education of physicians-in-training can decrease the risk for vascular catheter infectionR J Sherertz, E W Ely, D M Westbrook, et al.
Nature|November 8, 2013
Immunosuppressive CD71+ erythroid cells compromise neonatal host defence against infectionShokrollah Elahi, James M Ertelt, Jeremy M Kinder, et al.
British Journal of Cancer|June 13, 2014
Feasibility RCT of definitive chemoradiotherapy or chemotherapy and surgery for oesophageal squamous cell cancerJ M Blazeby, S Strong, J L Donovan, et al.
Pageof 19

Showing results (171-180 of 182) with videos related to

Sort By:
Pageof 19
Chimerism|October 15, 2013
Trogocytosis as a mechanistic link between chimerism and prenatal toleranceAmir M Alhajjat, Beverly S Strong, Emily T Durkin, et al.
Progress in Clinical and Biological Research|January 1, 1985
Sequential response patterns to chemotherapy and radiotherapy in head and neck cancer: potential impact of treatment in advanced laryngeal cancerW K Hong, G M O'Donoghue, S Sheetz, et al.
American Journal of Clinical Oncology|June 1, 1984
Induction bleomycin infusion in head and neck cancerJ D Popkin, W K Hong, R H Bromer, et al.
Journal of Clinical Apheresis|January 1, 1985
Plasma exchange in six patients with advanced cancers of the head and neckR H Seder, A E Katz, J J Keggins, et al.
Drug and Alcohol Dependence|June 24, 2023
Opioid and stimulant attributed treatment admissions and fatal overdoses: Using national surveillance data to examine the intersection of race, sex, and polysubstance use, 1992-2020A A Jones, R D Shearer, J E Segel, et al.
Cancer|July 15, 1983
A prospective randomized trial of methotrexate versus cisplatin in the treatment of recurrent squamous cell carcinoma of the head and neckW K Hong, S Schaefer, B Issell, et al.
American Journal of Clinical Oncology|June 1, 1983
Continuous vindesine infusion in advanced head and neck cancerJ D Popkin, R H Bromer, C W Vaughan, et al.
Annals of Internal Medicine|April 15, 2000
Education of physicians-in-training can decrease the risk for vascular catheter infectionR J Sherertz, E W Ely, D M Westbrook, et al.
Nature|November 8, 2013
Immunosuppressive CD71+ erythroid cells compromise neonatal host defence against infectionShokrollah Elahi, James M Ertelt, Jeremy M Kinder, et al.
British Journal of Cancer|June 13, 2014
Feasibility RCT of definitive chemoradiotherapy or chemotherapy and surgery for oesophageal squamous cell cancerJ M Blazeby, S Strong, J L Donovan, et al.
Pageof 19